Medanta is one of India’s largest private hospitals, with a multispecialty campus and a leading cancer institute. It integrates oncosurgery, radiation, hemato-oncology, and BMT. Its
infrastructure and large ICU support make it a hub for advanced therapies including CAR-T.
In Gurugram, hematology care is integrated into the Cancer Institute with multidisciplinary tumour boards, genetic testing, and advanced techniques like CD45RA and TCR α-β depletion, stem cell collection, donor lymphocyte infusions, and inherited blood disorder management (e.g., thalassemia, SCD),combining diagnostics, transplant, gene therapy, and counselling to offer personalized,high-impact care.
Medanta – The Medicity, spans a sprawling 43 acre campus and features around 1,300–1,391 operational beds, with over 270 ICU beds and more than 40 operating theatres.
It hosts over 30 medical specialties, employs 900+doctors, and integrates advanced infrastructure for super-specialty care across cardiology, oncology,neurosciences, orthopaedics, renal care, and more.
Medanta has consistently ranked among India’s top private hospitals for six consecutive years , offering state of the art medical technologies, robotic surgery, hybrid operating suites, and advanced ICUs.
Medanta – The Medicity is consistently ranked among India’s top hospitals: 2nd-best Private Hospital India (Newsweek, 2020–2021).
2nd-best Multi-Speciality Hospital by Outlook (2022)
2nd-best Cardiology Hospital (Times of India, 2022)
Internationally, 132nd in the World's Best Hospitals (Newsweek, 2022).
CMC Vellore has been consistently ranked among the top medical institutions in India for clinical excellence and academic contribution.
It has received national and international recognition for pioneering work in hematology, oncology, and transplant services.
The institution’s quality assurance standards and NABH accreditation highlight its leadership in medical education, patient safety, and compassionate healthcare delivery.
Apollo Hospitals, Mumbai, has received national and international awards for pioneering cancer care, patient safety, and clinical excellence. It is NABH and JCI accredited.
© 2025 CAR T-Shell Therapy. All rights reserved.
Harnessing the power of your immune system to fight cancer—personalized, innovative, and life-changing treatment.
